A recent long-term prospective study has demonstrated that coffee consumption by patients with autosomal dominant polycystic kidney disease (ADPKD) does not have a detrimental effect on kidney size or estimated glomerular filtration rate. We suggest that caffeine may, however, have a hypertensive effect in some ADPKD patients. Further research is needed before we can definitively state that caffeinated coffee consumption is harmless in ADPKD patients.
No takes yet. Share an insight, caveat, or question.
Tanner et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: